-
After 6 years, the guidelines for the treatment of nerve repair for idiopathic facial palsy have been updated and the key points are quick to see
Time of Update: 2023-02-02
*For medical professionals onlyAttached 5 major evaluation scales, collect quickly!Idiopathic facial nerve palsy, also known as facial neuritis, Bell's palsy, traditional Chinese medicine called mouth seclusion, mouth and eye skew, is the most common facial nerve disease, accounting for 60% ~ 75%, the incidence is (11.
-
Colchicine for liver and kidney damage, so that it is safe to adjust the dose
Time of Update: 2023-01-01
Second, adult liver injury ▍ 1, gout attack to prevent gout attack: For the prevention of gout attacks in patients with mild to moderate hepatic impairment, the recommended dose adjustment is not required, but patients should be closely monitored for adverse effects after colchicine use.
-
The favorable policies for the inheritance and development of traditional Chinese medicine are continuous, and the medium- and long-term development is optimistic
Time of Update: 2022-11-15
The inheritance and development of traditional Chinese medicine has been favorable, and the medium- and long-term development is optimistic (image source; Pharma Network) It is worth mentioning that on October 14 this year, the State Administration of Traditional Chinese Medicine also issued the "14th Five-Year Plan for the Development of Traditional Chinese Medicine Talents" (hereinafter referred to as the "Plan"), focusing on the specific tasks of the construction of various talent teams, and establishing clearer talent classification training goals.
-
Professor He Pengcheng: Through the fog, the innovative ADC drug Pola continues hope for DLBCL patients with CAR-T treatment failure
Time of Update: 2022-11-15
Figure 5 Real-world research in the UKIn summary, the Pola combination regimen has reliable efficacy, no safety concerns such as specific CRS, and the convenient application of ready-to-use drugs, which provides a new treatment option for patients with R/R DLBCL and CAR-T therapy failure.
-
Aging Cell Review︱ Zhang Hong/Chen Yingzhi/Tian Mei collaborated to review the mechanism of gut microbiota regulating microglia function in cognitive aging
Time of Update: 2022-05-30
Written by ︱ Zhou Rui editor ︱ Wang Sizhen Aging is an inevitable life process that almost all living things have to go through . In recent years, with the improvement of living standards and the
-
Hengrui, Chia Tai Tianqing, and Fosun Pharma lead the IND application of Category 1 new drugs
Time of Update: 2022-02-16
Looking back at the IND applications for Category 1 new drugs in recent years, it can be found that the number of applications has grown rapidly since 2015.
After almost every major reform measure, the number of new Class 1 drugs applied for clinical applications will increase substantially once .
-
The nose becomes wider and the lips become thicker. The longer it gets, the uglier it becomes. Beware of pituitary tumors
Time of Update: 2021-08-01
Wang Mo, deputy chief physician of the Department of Neurosurgery of the Second People's Hospital of Guangdong Province, reminded him to beware of growth hormone-type pituitary tumors .
-
Huizhi Miao Tianxiang, Bayer Jiangwei both retired, Eli Lilly, and GSK have changed
Time of Update: 2021-06-11
At the same time, Bayer announced that starting from July 1, 2021, Chen Ying, the current senior vice president of the Bayer Group's prescription drug division and head of the China market, will take over Zhou Xiaolan as the president of the prescription drug division of the Asia-Pacific region.
-
CDK4/6 inhibitors compete for early breast cancer: Why did Abesili come first
Time of Update: 2021-01-10
Common adverse events include diarrhea, fatigue and neogenic granulocyte reduction, mostly at levels 1-2; , according to the MonarchE trial, Abesili became the first and only CDK4/6 inhibitor to demonstrate improvement in IDFS in patients with high-risk HR-/HER2-early breast cancer.
-
Whose tears are flying when the tide of drug procurement hits
Time of Update: 2020-11-07
During the period, but also mixed with the national regional bidding mad phenomenon: there are tender consultation calls have not been answered, or answer the phone often care about his: "Please take the document as the standard, please take the notice as the first, please take the latest requirements of the official website as the standard." the bidders questioned whether they had called the voice self-service system.
-
The latest results of the 3rd Phase 3 study of Fuhong Han's Quto-Zhu single-resistance international multi-center were released
Time of Update: 2020-10-06
Phase 3 clinical trial and PopPK model showed that HLX02 was equivalent to the efficacy, safety and pharmacogenetics of the original virultural bead monoantin in HER2-positive metastasis breast cancer patients.
-
Food label management measures for advice on production and shelf life text height shall not be less than 3 mm
Time of Update: 2020-08-20
like this food, the obvious position is only marked shelf life, but the production date has to look for half a day to find in the corner of the blue area, and blurred.
-
Beware of monopolies! Drug price behavior
Time of Update: 2019-11-11
The pharmaceutical industry has always been the focus of anti-monopoly law enforcement In the first half of this year, according to relevant media reports, the price of nitroglycerin tablets, which us
-
Announcement of the latest news of GMP certification cancellation
Time of Update: 2019-11-01
In the future, the supervision and inspection records will become the proof of the enterprise's compliance with GMP requirements, because the law requires that all the supervision results be made publ
-
In 2018, 53 new drugs have been approved by the FDA. These 5 have the most commercial potential
Time of Update: 2018-11-19
According to the data recently released by EP vantage under evaluatepharma, a pharmaceutical market research institution, in 2017, the US FDA approved 57 new drugs, the largest number of new drugs in
